KOREA UNITED PHARM INC Q3 operating profit KRW 2.8 billion, down 77.4% from a year earlier; net loss KRW 7.0 billion
AI summary · Not investment advice
United Pharm sold KRW 68.1 billion worth in Q3 and earned KRW 2.8 billion from its main business, down 77.4% from a year earlier and 78.8% from the previous quarter.
Operating profit · 3 months
KRW 2.8 billion
Key facts
- Revenue (3 months)
- KRW 68.1 billion
- Net income (3 months)
- KRW -7.0 billion
- Period
- Q3 (cumulative 2026.01.01 ~ 2026.09.30)
- Revenue (prior-year 3 months)
- KRW 74.4 billion
- Revenue (year to date)
- KRW 219.1 billion
- Operating profit (prior-year 3 months)
- KRW 12.5 billion
- Operating profit (year to date)
- KRW 27.4 billion
- Net income (prior-year 3 months)
- KRW 13.5 billion
- Net income (year to date)
- KRW 44.7 billion
Commentary
AI commentary · Not investment advice
What happened
United Pharm reported its separate-basis results for the third quarter of 2026. Sales for the 3 months were KRW 68.07 billion. That is 8.5% lower than a year earlier and 11.9% lower than the previous quarter.
In the company's terms
Operating profit (profit from the core business) for the 3 months was KRW 2.82 billion. A year earlier it was KRW 12.51 billion, so it fell 77.4%. It fell 78.8% from the previous quarter.
What changes for shareholders
Net income (the final profit after taxes and other costs) for the 3 months was a loss of KRW 7.02 billion. A year earlier it was a profit of KRW 13.54 billion. The company moved from a profit in the previous quarter to a loss this quarter.
For the year to date, sales were KRW 219.11 billion. Operating profit was KRW 27.38 billion. Net income was KRW 44.67 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
K